Christoph Borchers
Funding strengthens protein research
The Ring
New funding in proteomics research
Media release
3-D models could result in custom drugs
Media release
Funding for UVic proteomics research
Media release
- < Newer
- 1
- Older >
Improved diagnosis and treatment of a range of diseases such as cancer and Alzheimer's is the goal of more than $18 million in funding awarded last month to two national platforms
in which UVic plays a key role.
Improved diagnosis and treatment of a range of diseases such as cancer and Alzheimer's will be the outcome of more than $18 million in funding awarded today to two national
research platforms in which the University of Victoria plays a key role. UVic's Christoph Borchers, an internationally recognized protein chemist and director of the UVic-Genome BC Proteomics
Centre, is leading a new pan-Canadian proteomics research platform.
Unraveling the mysteries of proteins whose changed structures cause conditions such as Alzheimer’s and Parkinson’s disease is key to the development of new drug treatments for
difficult neurological disorders, says University of Victoria biochemist Christoph Borchers.
A project co-led by UVic biochemist Christoph Borchers will use more than $3.8 million in new funding from Genome Canada to make mouse models more powerful and meaningful to the
study of health and disease. Also funded is UVic chemist Fraser Hof, who receives $238,800 to investigate “methylation”—the smallest form of biochemical control switch.